Literature DB >> 2186176

Sequence-specific binding of DNA by the Moloney murine leukemia virus integrase protein.

P A Krogstad1, J J Champoux.   

Abstract

Genetic studies have indicated that integration of retroviral DNA into the host genome depends on the presence of the inverted repeats at the free termini of the long terminal repeats on the unintegrated DNA and on the product of the 3' end of the pol gene (the integrase [IN] protein). While the precise function of the Moloney murine leukemia virus IN protein is uncertain, others have shown that it is a DNA-binding protein and functions in the processing of the inverted repeats prior to integration. By using site-directed mutagenesis, we cloned and expressed the IN protein in Escherichia coli. Crude extracts of total cellular protein were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose filters, denatured in guanidine, renatured, and incubated with oligonucleotide probes. Single- and double-stranded oligonucleotides corresponding to the termini of unintegrated linear viral DNA were specifically bound by the IN protein in this assay. These data suggest that the role of the Moloney IN protein in the early steps of integration involves sequence-specific recognition of the DNA sequences found at the ends of the long terminal repeats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186176      PMCID: PMC249460     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence.

Authors:  M J Roth; P L Schwartzberg; S P Goff
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  Studies of the binding of Escherichia coli RNA polymerase to DNA. I. The role of sigma subunit in site selection.

Authors:  D C Hinkle; M J Chamberlin
Journal:  J Mol Biol       Date:  1972-09-28       Impact factor: 5.469

3.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

4.  Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription.

Authors:  G Dreyfuss; S A Adam; Y D Choi
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

5.  Selective cleavage in the avian retroviral long terminal repeat sequence by the endonuclease associated with the alpha beta form of avian reverse transcriptase.

Authors:  G Duyk; J Leis; M Longiaru; A M Skalka
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

6.  Nicking-closing activity associated with bacteriophage lambda int gene product.

Authors:  Y Kikuchi; H A Nash
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  Avian retrovirus pp32 DNA-binding protein. I. Recognition of specific sequences on retrovirus DNA terminal repeats.

Authors:  T K Misra; D P Grandgenett; J T Parsons
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.

Authors:  J B Konopka; R L Davis; S M Watanabe; A S Ponticelli; L Schiff-Maker; N Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

9.  Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration.

Authors:  C Shoemaker; S Goff; E Gilboa; M Paskind; S W Mitra; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus.

Authors:  J J Kopchick; J Harless; B S Geisser; R Killam; R R Hewitt; R B Arlinghaus
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  9 in total

1.  Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis.

Authors:  S R Mumm; D P Grandgenett
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.

Authors:  L B Kong; D An; B Ackerson; J Canon; O Rey; I S Chen; P Krogstad; P L Stewart
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  HIV-1 integrase blocks infection of bacteria by single-stranded DNA and RNA bacteriophages.

Authors:  R Levitz; K Drlica; E Murphy
Journal:  Mol Gen Genet       Date:  1994-05-25

5.  DNA binding activities of the Caenorhabditis elegans Tc3 transposase.

Authors:  S D Colloms; H G van Luenen; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

6.  Detection and characterization of a functional complex of human immunodeficiency virus type 1 integrase and its DNA substrate by UV cross-linking.

Authors:  T Yoshinaga; Y Kimura-Ohtani; T Fujiwara
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites.

Authors:  S Basu; H E Varmus
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Substrate specificity of recombinant human immunodeficiency virus integrase protein.

Authors:  R L LaFemina; P L Callahan; M G Cordingley
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2.

Authors:  D C van Gent; Y Elgersma; M W Bolk; C Vink; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.